Syndesi Therapeutics

Syndesi Therapeutics

Developer of a series of novel, procognitive SV2A modulators. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€118m (Public information from Mar 2022)
Company register number 0686.599.355
Wavre Walloon Brabant (HQ)
Authorizing premium user...